Amer Ghavanini

Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology

Health EN ↓ 207 episodes

A selection of recent neurology papers is summarized and discussed, with a focus on review articles and those that have the potential to change clinical practice. Please note that AI has been used in generating the content.

Author

Amer Ghavanini

Category

Health

Podcast website

podcasters.spotify.com

Latest episode

Jul 6, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Shingles Vaccination and Reduced Dementia Risk 19.04.2026

This study examines whether receiving the  live-attenuated herpes zoster vaccine  reduces the risk of developing  dementia  among older adults in Canada. Researchers utilized a  natural experiment  in Ontario, where government funding for the vaccine was strictly determined by specific  date-of-birth eligibility thresholds . By comparing individuals born just days apart, the authors isolated the v...

Approach to Asymptomatic HyperCKemia - EAN Guidelines 19.04.2026

The provided text outlines the  2024 European Academy of Neurology (EAN) guidelines  for diagnosing adults who exhibit elevated creatine kinase levels without significant symptoms. Because this condition can stem from  non-neuromuscular factors  like exercise and medication or hidden  genetic disorders , the authors establish a standardized testing sequence to improve diagnostic accuracy. The expe...

Predictive T-Cell Biomarkers for Checkpoint Inhibitor Response in PML 15.04.2026

Progressive multifocal leukoencephalopathy (PML)  is a devastating brain infection caused by the  JC virus  following immune system failure. These sources detail how the virus transforms into a  neurotropic phenotype  to destroy brain tissue, specifically targeting  subcortical white matter  and creating distinct patterns on  MRI scans . Diagnosis relies on the  Berger criteria , which combine cli...

Practical Strategies for SCIg Maintenance Therapy in CIDP Patients 13.04.2026

This clinical research article investigates the effectiveness and practical management of  subcutaneous immunoglobulin (SCIg)  as a maintenance therapy for individuals with  chronic inflammatory demyelinating polyneuropathy (CIDP) . By analyzing twenty retrospective cases from various U.S. medical centers, the authors explore the  transition process from intravenous to subcutaneous administration...

Treatment of Spinal Cavernous Malformations: A Systematic Review 12.04.2026

This  systematic review  evaluates the  optimal treatment strategies  for  spinal cavernous malformations , which are rare vascular lesions within the spinal cord. Researchers analyzed  50 studies  involving over  2,300 patients  to compare the results of  surgical intervention  against  conservative management . While  surgery  was the most common approach and often led to  neurological improveme...

Augmenting Diagnostic Yield From Genomic Testing in Neurological Diseases 10.04.2026

Despite the high utility of clinical genome sequencing (GS) in diagnosing rare neurological disorders, a significant proportion of patients remain molecularly unsolved or receive results involving variants of uncertain significance (VUS). To bridge this diagnostic gap, neurologists should employ a multi-modal strategy incorporating targeted functional studies and systematic data reanalysis. When D...

Spinal and Bulbar Muscular Atrophy: Pathogenesis and Therapeutic Horizons 06.04.2026

This comprehensive review details  Spinal and Bulbar Muscular Atrophy (SBMA) , a rare genetic disorder triggered by a specific mutation in the  androgen receptor gene . The text explains how this defect leads to the  toxic accumulation  of proteins, which causes the gradual decay of both  motor neurons  and  skeletal muscle . Beyond physical weakness and swallowing difficulties, the source highlig...

Phase 3 Trial of Brepocitinib in Dermatomyositis 06.04.2026

This source describes a  phase 3 clinical trial  evaluating the efficacy and safety of  brepocitinib , an oral medication designed to treat adults with  dermatomyositis . The study compared two different doses of the drug against a placebo over a one-year period, specifically focusing on patients whose condition had not responded well to previous therapies. Researchers found that the  30-mg dose  ...

Are Patients with Essential Tremor at Increased Risk of Parkinson's Disease? 29.03.2026

This study investigates the prevalence of  phosphorylated alpha-synuclein (P-Syn) , a key biological marker for  Parkinson disease , in patients diagnosed with  essential tremor (ET) . Researchers found that  37% of ET patients  tested positive for these protein deposits in their skin, a rate significantly higher than that found in healthy individuals. The presence of these deposits, along with hi...

Efficacy of Hyperbaric Oxygen in Neurological Disorders 28.03.2026

This review examines the  therapeutic role of hyperbaric oxygen therapy (HBOT)  as a neuromodulatory tool for treating various brain disorders. The text explains that by saturating blood plasma with  supraphysiological oxygen levels , HBOT can restore  mitochondrial function , reduce swelling, and trigger regenerative genetic pathways. While meta-analyses suggest significant  cognitive and motor b...

Recent Advances in Targeted Therapies for Adult Gliomas 28.03.2026

The provided text details the  evolving landscape of adult glioma treatment , highlighting a significant transition from traditional histology to  molecularly-driven diagnostics and targeted therapies . Recent  FDA approvals  have introduced precision agents such as  vorasidenib  for IDH-mutant tumors,  dabrafenib-trametinib  for BRAF-mutated cases, and  dordaviprone  for specific midline gliomas....

Modafinil for Excessive Daytime Sleepiness in Narcolepsy: A Meta-Analysis 24.03.2026

This  systematic review and meta-analysis  evaluates the effectiveness of  modafinil  in managing  excessive daytime sleepiness  associated with  narcolepsy . By synthesizing data from multiple clinical trials, the researchers confirmed that the drug significantly improves  objective wakefulness  and reduces  subjective drowsiness  compared to placebos. The authors note that while modafinil is a ...

The European Medicines Agency's Assessment of Lecanemab and Donanemab for Alzheimer’s Disease 23.03.2026

This article examines the  European Medicines Agency’s  recent evaluation and approval of  lecanemab  and  donanemab , the first monoclonal antibodies authorized in the EU to slow  early Alzheimer’s disease . While these therapies demonstrate a statistically significant reduction in  cognitive decline , the authors highlight a complex  benefit-risk assessment  due to modest clinical effects and se...

The Vital Role of PET/CT in NF1 Cancer Surveillance 22.03.2026

This research study evaluates the effectiveness of  18F-FDG PET/CT scans  as a proactive tool for detecting hidden cancers in adults with  Neurofibromatosis type 1 (NF1) . While patients with this genetic disorder are highly susceptible to both benign and malignant tumors, traditional monitoring often struggles to identify aggressive transformations in early, asymptomatic stages. By reviewing a co...

A Diagnostic Assay for Multiple Sclerosis Based on EBV 17.03.2026

Researchers have developed a  second-generation diagnostic test  to identify a specific  autoantibody signature  that can predict  multiple sclerosis (MS)  years before clinical symptoms appear. By isolating a  monoclonal antibody  from an MS patient’s B cells, the study identified a  conserved protein motif  that triggers an immune response. This signature appears to result from  molecular mimicr...

Radiologically Isolated Syndrome: A Practical Clinical Guide 15.03.2026

Radiologically isolated syndrome (RIS)  describes a situation where a person's brain or spinal cord scans show nerve damage typical of  multiple sclerosis (MS)  despite the individual having no physical symptoms. While roughly half of those identified with these incidental findings may eventually face a clinical diagnosis, others might never experience illness, making the decision to  investig...

Stenting vs. Shunting for Sight-Threatening Intracranial Hypertension 15.03.2026

This paper explores the medical debate regarding  surgical interventions  for patients facing vision loss due to  idiopathic intracranial hypertension (IIH) . Currently, doctors must choose between  cerebrospinal fluid shunting  and  dural venous sinus stenting  without the guidance of high-quality, comparative data. The authors highlight that existing research often suffers from  publication bias...

AI-Driven Biomarkers in Neurology: A Narrative Review 10.03.2026

The provided text outlines a  narrative review  detailing how  artificial intelligence  is revolutionizing the discovery of  biomarkers  for various  neurological conditions . Traditional diagnostic methods often struggle with biological complexity and delayed detection, but  AI algorithms  can integrate vast, multimodal datasets to identify subtle disease patterns. The sources highlight significa...

Pompe Disease - Advances in Diagnosis and Management 08.03.2026

This review examines current breakthroughs in the understanding and treatment of  Pompe disease , a genetic disorder caused by a deficiency in the  GAA enzyme  that leads to harmful glycogen buildup. The text highlights how  early diagnosis  is improving through umbilical cord blood testing in  newborn screening , while next-generation  enzyme replacement therapies  (ERTs) like avalglucosidase alf...

Hallmarks of Secondary Headaches 07.03.2026

This academic review explores the complex landscape of  secondary headache disorders , which are head pains caused by underlying medical conditions rather than being standalone diseases. The authors categorize these headaches into groups such as  trauma, vascular issues, infections, and metabolic disturbances , highlighting that while they often mimic primary disorders like migraine, they can sign...

Del-desiran Therapy for Myotonic Dystrophy Type 1 04.03.2026

This paper details the results of a  Phase 1-2 clinical trial  investigating a new treatment for  myotonic dystrophy type 1 , a progressive and currently incurable neuromuscular disease. The study tested  del-desiran , an innovative therapy that combines a monoclonal antibody with an oligonucleotide to target and reduce toxic genetic transcripts in muscle tissue. Researchers found that the drug su...

Long-Term Efficacy and Safety of Tofersen in SOD1-ALS Patients 03.03.2026

This paper details the final long-term results of the  VALOR study  and its  open-label extension , which investigated the efficacy of  tofersen  in adults with  SOD1-ALS . Researchers compared patients who began the drug immediately to those who switched from a  placebo  after six months, finding that  earlier treatment  led to better outcomes in  muscle strength ,  breathing , and  physical func...

Movement Disorders and Oculomotor Abnormalities in Whipple's Disease 02.03.2026

This  systematic review  explores the neurological manifestations of  Whipple’s disease , a rare infection caused by the bacterium  Tropheryma whipplei . The authors analyzed 168 cases to identify key  movement disorders  and  oculomotor abnormalities , noting that  supranuclear gaze palsy  and  myorhythmia  are the most frequent diagnostic indicators. Specifically, the study emphasizes that uniqu...

Acute Disseminated Encephalomyelitis (ADEM): Review 01.03.2026

This review examines  acute disseminated encephalomyelitis (ADEM) , a rare immune-mediated disorder characterized by widespread inflammation and demyelination in the  central nervous system . Primarily affecting children, ADEM often follows an infectious or vaccine-related trigger, likely initiated by  molecular mimicry  where the immune system mistakenly attacks host myelin. The sources outline a...

A refresher on abnormal spontaneous EMG activities 27.02.2026

This medical text details the evaluation of  abnormal spontaneous electromyographic (EMG) activity , which serves as a vital diagnostic indicator for various  neuromuscular disorders . While healthy skeletal muscles typically remain electrically quiet at rest, the source identifies specific  waveforms and firing patterns  that signal underlying nerve or muscle pathology. It categorizes these irreg...

Listen to the Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.